Found 0 matching trials
Safety and Immunogenicity Study in Adults of AZD1222 and rAd26-S Administered as Heterologous Prime Boost Regimen for the Prevention of Coronavirus Disease 2019 (COVID-19) PHASE1 This is a Phase I/II, parallel group, single blinded (participant blinded),...
Show More Learn More & Join Trial
Clinical Trial of the Immunogenicity, Safety, and Efficacy of the Gam-COVID-Vac Vaccine Against COVID-19 in Venezuela PHASE3 Randomized, double-blind, placebo controlled clinical trial of immunogenici...
Show More Location
Multiple Locations
Learn More & Join Trial
An Open Study of the Safety, Tolerability and Immunogenicity of "Gam-COVID-Vac Lyo" Vaccine Against COVID-19 PHASE1 the purpose of this study: to evaluate the safety, tolerability and immunog...
Show More Location
Sechenov First Moscow State Medical University
Learn More & Join Trial
Study in Adults of AZD1222 and rAd26-S Administered as Heterologous Prime-Boost Regimen for the Prevention of COVID-19 PHASE1 The objective is to evaluate the safety and immunogenicity of AZD1222 given...
Show More Location
OJSC Clinical and Diagnostic Center Euromedservice
Learn More & Join Trial
The Study of "Gam-COVID-Vac" Vaccine Against COVID-19 With the Participation of Volunteers of 60 y.o and Older PHASE2 The purpose of this study: to assess the safety, tolerability and immunogen...
Show More Location
Federal state budgetary institution "Central clinical hospital with polyclinic" Of the office Of the President of the Russian Federation
Learn More & Join Trial